- Location
cancer therapy
"-
SGH Resulted in The Establishment of The Region's First Circulating Tumour Cell Centre
Jan 19, 2014A collaboration between National Cancer Centre Singapore (NCCS) and Clearbridge BioMedics, in partnership with the Pathology Department at Singapore General Hospital (SGH) has resulted in the establishment of the region's first Circulating ...
-
Immunocore Entered Into an Oncology Collaboration and Licensing Agreement with MedImmune
Jan 9, 2014Immunocore Limited, the Oxford-based biotechnology company developing novel biological drugs to treat cancer and viral disease, today announced that it has entered into an oncology research collaboration and licensing agreement with ...
Tags: Immunocore, oncology research, collaboration and licensing agreement
-
Scientists Say They May Have Found a Way to Predict Survival From Ovarian Cancer
Dec 26, 2013By counting the number of cancer-fighting immune cells inside tumors, scientists say they may have found a way to predict survival from ovarian cancer. The researchers developed an experimental method to count these cells, called ...
-
Cancer Death Rates Continue to Decline in The United States
Dec 26, 2013Cancer death rates continue to decline in the United States, mainly because anti-smoking efforts have caused a drop in lung cancer deaths, researchers report. From 2001 through 2010, death rates for all cancers combined decreased by 1.8 ...
Tags: cancer death rates, US, anti-smoking efforts
-
Sutro Biopharma Has Received $26m in a Series D Financing
Dec 13, 2013Sutro Biopharma has received $26m in a Series D financing, which will be used for the expansion of its proprietary immuno-oncology product pipeline. The company is currently using its cell-free protein synthesis technology to develop new ...
-
New Technologie to Improve Enterprise-Wide Medication Management Is Declared by Carefusion
Dec 11, 2013CareFusion, a global medical technology company, has announced multiple new technologies across its device and software platforms to help improve the safety, efficiency and cost of intravenous (IV) medications to enhance enterprise-wide ...
Tags: technology, health, medicine
-
Novogen Has Announced The Filing of a Family of Provisional Patents in The US
Nov 29, 2013Novogen, a biotechnology company, has announced the filing of a family of provisional patents in the US covering anti-tropomyosin (ATM) drug technology. ATM drugs represent an entirely novel approach to anti-cancer therapy, blocking the ...
-
Celgene's Pomalidomide Oral Anti-cancer Therapy Has Won European Commission Approval
Aug 13, 2013Celgene International's oral anti-cancer therapy Pomalidomide has won European Commission approval as treatment for patients with relapsed/refractory multiple myeloma (rrMM), a rare form of blood cancer, in combination with dexamethasone. ...
Tags: Anti-Cancer Therapy
-
FDA Has Cleared Gilotrif as a New Medication for Patients with Late Stage NSCLC
Jul 16, 2013The US Food and Drug Administration (FDA) has cleared Boehringer Ingelheim's tyrosine kinase inhibitor Gilotrif (afatinib) as a new medication for patients with late stage (metastatic) non-small cell lung cancer (NSCLC). The approval also ...
Tags: FDA, Lung Cancer Therapy, Medicine
-
Health Ministry Inspect That FDI Limit Is Not at The Cost of The Public Health Goals
Jul 16, 2013India’s Health ministry is planning to organize an inter-ministerial meeting to inspect that the current foreign direct investment (FDI) limit in the pharma industry is not at the cost of the public health goals. The Department of ...
-
The EMA Committee for CHMP Has Adopted a Positive Opinion
Jun 4, 2013The European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion for Celgene International's oral anti-cancer therapy Pomalidomide. The positive results from the MM-003 study of ...
-
US FDA Has Approved Xofigo for The Treatment of Symptomatic Prostate Cancer Therapy
May 17, 2013The US FDA has approved Xofigo (radium Ra 223 dichloride) for the treatment of symptomatic late-stage (metastatic) castration-resistant prostate cancer spread to bones but not to other organs in men. The therapy is indicated for men whose ...
-
Lorus Therapeutics' Novel Therapy, Il-17e, Has Been Granted US Patent
Jan 24, 2013The United States Patent and Trademark Office has issued a patent covering the methods of cancer treatment with Lorus Therapeutics' novel therapy, IL-17E. Treatment methods with IL-17E include single and combination therapy along with ...
Tags: IL-17E, Lorus Therapeutics, Cancer Therapy, US Patent
-
Expanded Use of Genzyme Thyrogen Is Cleared by European Commission
Dec 10, 2012The European Commission has cleared the expanded use of Genzyme's Thyrogen(thyrotropin alfa)cancer therapy for patients with postoperative thyroid remnant ablation. The new approval allows administration of a reduced dose of radioiodine ...
Tags: European Commission, Genzyme, Thyrogen, cancer therapy
-
Bayer Healthcare Filed NDA with The FDA Seeking Approval for Inhibitor Regorafenib
Dec 5, 2012Bayer HealthCare has filed a new drug application (NDA) with the FDA seeking approval for the oral multi-kinase inhibitor regorafenib to treat patients with metastatic colorectal cancer (mCRC). The company has even filed an application ...
Tags: oral multi-kinase inhibitor regorafenib, metastatic colorectal cancer
Related Products
-
U-Frame Non-Stick Thermoplastic Radiotherapy Head Immobilization Mesh Mask with Suitable Molding Time
-
U-Frame Low Temperature Thermoplastic Head Mask for Cancer Oncology Radiotherapy Immobilization
-
CE ISO Certified Factory Price O-Type 5-Clamp Head Neck Shoulder Radiotherapy Thermoplastic Immobilization Mask
-
CE ISO Certified S-Type 9-Pin Head Neck Shoulder Radiotherapy Thermoplastic Immobilization Mask
-
O Type 3-Clamp Aquaplast Medical Radiotherapy Head Immobilization Mesh Thermoplastic Mask with Orfit/Klarity Baseplate Adaptive
-
O-Type Thermoplastic Head Shoulder Radiotherapy Immobilization Mask with CE ISO FDA Certification
